Pfizer will have to cut price of AML drug Mylotarg after NICE rulingNICE blocks access to 65% of patients on cost grounds Share XPfizer will have to cut price of AML drug Mylotarg after NICE rulinghttps://pharmaphorum.com/news/pfizer-cut-price-mylotarg/